Trial
NCT02546492
Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
University of Alabama at Birmingham
Condition
Transplant Glomerulopathy
Intervention
Acthar gel
Why stopped
Slow Enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-06